# OpenAI's $40M bet on cancer vaccines

> A North Carolina cancer center just got $40 million to build the biological data AI needs to design better tumor vaccines.
- Title: OpenAI's $40M bet on cancer vaccines · ABC7 Los Angeles
- Summary: A North Carolina cancer center just got $40 million to build the biological data AI needs to design better tumor vaccines. Personalized cancer vaccines keep…
- Keywords: cancer research, openai, vaccines, immunotherapy, news, local, OpenAI's, 40M, bet, cancer, ABC7 Los Angeles
- Source: ABC7 Los Angeles — https://abc7.com/post/openai-foundation-gifts-unc-lineberger-comprehensive-cancer-center-40-million-make-vaccines-more-effective-patients/19834554
- Published: 2026-09-15T13:38:57+00:00
- Read time: 1 min
- Topics: cancer research, openai, vaccines, ai, immunotherapy, news, local
## Forty million for UNC
The OpenAI Foundation gave UNC Lineberger Comprehensive Cancer Center $40 million. The foundation is the nonprofit parent that governs the for-profit OpenAI Group PBC.
## The vaccines pick badly
Personalized cancer vaccines are finally showing clinical results, but most die in development. The reason, per UNC's Dr. Alex Rubinsteyn, is that the design choices are too arbitrary.

> Personalized cancer vaccines are finally starting to show signs of clinical efficacy, but many fail in the development process because they are too arbitrary.
## Data is the bottleneck
AI can help design treatments only if it has biology to learn from. The grant pays for generating that data, not for building another model.

> AI has enormous potential to help researchers design better cancer treatments, but that progress depends on having the right biological data to learn from.
## Open to everyone
The gift launches the foundation's second science program, Public Data for Health, which funds open-access data sets any researcher or AI tool worldwide can use.
## Two tracks at once
The data will train better AI methods for picking tumor antigens. In parallel, UNC runs clinical trials comparing vaccine formulations in triple-negative breast cancer.
## Red flags on tumors
Vaccines are built from a patient's own tumor and immune cells. Proteins on the tumor surface act like a red flag in a bullring, teaching the immune system exactly what to charge.
## Key takeaway

Personalized cancer vaccines keep failing because the data behind antigen selection is thin, and this grant is aimed squarely at that gap.